Researchers in China used machine learning — a type of artificial intelligence in which computers detect patterns in datasets and then make predictions — to create diagnostic and prognostic models for use in idiopathic pulmonary fibrosis (IPF). Using the new models, the team observed gene activity changes suggestive of…
Machine learning helps construct diagnostic models for IPF
When I talk to patients, caregivers, or family members, almost all of them can recall the details of the pertinent diagnosis. After all, it’s a monumental life event. What each of us hears and how it’s interpreted can vary. When I was diagnosed with idiopathic pulmonary fibrosis (IPF)…
CS014, a treatment candidate for idiopathic pulmonary fibrosis (IPF), was found to be safe and well tolerated in healthy volunteers in a Phase 1 clinical trial, according to new data from developer Cereno Scientific. Further, the experimental medication reached levels in the bloodstream that the company predicts will…
Some truly horrific events have occurred in recent weeks. The flash flooding that began in the early hours of July 4 along the Guadalupe River in Texas has claimed 134 lives as of this writing, with dozens more still missing or unaccounted for. Emergency situations are dangerous, but even more…
Endeavor Biomedicines’ oral treatment candidate taladegib (ENV-101) has been granted orphan drug designation in the U.S. and the European Union as a treatment for idiopathic pulmonary fibrosis (IPF) In both regions, orphan drug status is intended to incentivize the development of medications for rare diseases. In the EU,…
Joy is a simple three-letter word, but it can be elusive at times for those of us in the pulmonary fibrosis community. Patients and caregivers alike may often feel like no joy is to be found. When I was diagnosed with idiopathic pulmonary fibrosis (IPF) in January…
An experimental oral therapy for idiopathic pulmonary fibrosis (IPF) has been tolerated well in an ongoing Phase 2 clinical trial, according to interim data announced by its developer GRI Bio. After reviewing interim data from 24 patients treated with GRI-0621 for six weeks, an independent data monitoring…
This column is scheduled to publish at 10 a.m. Eastern time on July 10, 2025. Four years earlier at this hour, I was undergoing a bilateral lung transplant at Inova Fairfax Hospital here in Virginia. I’d been moved into surgery at 3 a.m., about seven hours earlier. Today, I…
It’s been hotter than usual here in the mid-Atlantic. Temperatures in the upper 90s, flirting with 100 F, plus high humidity made it feel like 107 to 115 F. If I had to sum it up in a single word, I’d pick “miserable.” After my diagnosis of idiopathic…
The National Institutes of Health has awarded $219,000 to fund a project at the University of Texas at Tyler aimed at developing a treatment for radiation-induced pulmonary fibrosis (PF) which can occur after cancer radiation therapy. The study, led by Sreerama Shetty, PhD, a professor at UT Tyler, will…
